Seema Sheoran
Stock Analyst at Rodman & Renshaw
(1.61)
# 3,477
Out of 5,023 analysts
7
Total ratings
42.9%
Success rate
n/a
Average return
Main Sectors:
Top Industries:
Stocks Rated by Seema Sheoran
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| QNCX Quince Therapeutics | Initiated Coverage: Buy | $70 | $29.20 | +139.73% | 1 | Sep 24, 2026 | |
| ELDN Eledon Pharmaceuticals | Initiated Coverage: Buy | $12 | $2.49 | +381.93% | 1 | Jul 21, 2026 | |
| NGNE Neurogene | Initiated Coverage: Buy | $70 | $25.65 | +172.90% | 1 | Jun 3, 2026 | |
| AVXL Anavex Life Sciences | Initiated Coverage: Buy | $20 | $1.82 | +998.90% | 1 | May 4, 2026 | |
| CAMP Camp4 Therapeutics | Initiated Coverage: Buy | $7 | $4.00 | +75.00% | 1 | Apr 14, 2026 | |
| SABS SAB Biotherapeutics | Initiated Coverage: Buy | $13 | $2.98 | +336.24% | 1 | Apr 2, 2026 | |
| SGMT Sagimet Biosciences | Initiated Coverage: Buy | $28 | $9.14 | +206.35% | 1 | Mar 26, 2026 |
Quince Therapeutics
Sep 24, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $29.20
Upside: +139.73%
Eledon Pharmaceuticals
Jul 21, 2026
Initiated Coverage: Buy
Price Target: $12
Current: $2.49
Upside: +381.93%
Neurogene
Jun 3, 2026
Initiated Coverage: Buy
Price Target: $70
Current: $25.65
Upside: +172.90%
Anavex Life Sciences
May 4, 2026
Initiated Coverage: Buy
Price Target: $20
Current: $1.82
Upside: +998.90%
Camp4 Therapeutics
Apr 14, 2026
Initiated Coverage: Buy
Price Target: $7
Current: $4.00
Upside: +75.00%
SAB Biotherapeutics
Apr 2, 2026
Initiated Coverage: Buy
Price Target: $13
Current: $2.98
Upside: +336.24%
Sagimet Biosciences
Mar 26, 2026
Initiated Coverage: Buy
Price Target: $28
Current: $9.14
Upside: +206.35%